Top in GI: Fecal microbiota transplantation, persistent dysphagia

A new study showed that fecal microbiota transplantation appeared to be safe and effective against Clostridioides difficile infection during a 2-year follow-up period. It was the top story in gastroenterology last week.

Another top story explored the use of pneumatic vs. sham dilation in patients with persistent dysphasia who underwent antireflux surgery.

Read these and more top stories in gastroenterology below:

FMT appears safe long term for recurrent C. diff

Fecal microbiota transplantation appeared safe in patients with recurrent Clostridioides difficile infection with low risk for transmission of infection, according to study results. Read more.

Pneumatic vs sham dilation not more effective for dysphagia after antireflux surgery

Pneumatic dilation with a 35-mm balloon compared with sham dilation was not superior for the treatment of persistent dysphagia after fundoplication, according to a study published in Gut. Read more.

Q&A: Patient-derived organoid model may help tailor treatment for patients with UC

A study published in the Nature Communications concluded that a patient-derived organoid model will provide insights into pathogenesis of ulcerative colitis, which may help tailor care to the individual patient. Read more.

Calprotectin ‘most useful’ biomarker for IBD during COVID-19

A presenter at the Crohn’s and Colitis Congress highlighted the importance of biomarkers in determining disease activity in inflammatory bowel disease, especially in the era of COVID-19. Read more.

Machine learning model may influence individualized care of Crohn’s disease in children

A machine learning image model describing Crohn’s disease phenotypes may impact individualized care for children with Crohn’s, according to a presenter at the Crohn’s and Colitis Congress. Read more.